Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type ; Application
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
Frequently Asked Questions
North America accounted for the largest share of the market in 2023.
Glanbia Plc; NOW Health Group Inc; Amway Corp; Nature's Bounty; Garden of Life LLC; Danone SA; GNC Holdings, LLC; Quest Nutrition LLC; Kellanova; and Chobani LLC are a few of the key players operating in the nutraceuticals market.
Consumer focus on preventive health, and innovations and strategic developments by market players are major factors contributing to the growth of the market.
Plant-based and organic nutraceuticals are likely to emerge as key trends in the market in the future.
The nutraceuticals market size is projected to reach US$ 895.76 billion by 2031.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Nutraceuticals Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
4.2.1 Porter's Five Forces Analysis
4.2.2 Bargaining Power of Suppliers
4.2.3 Bargaining Power of Buyers
4.2.4 Threat of New Entrants
4.2.5 Competitive Rivalry
4.2.6 Threat of Substitutes
4.3 Ecosystem Analysis
4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors or Suppliers
4.3.4 Retailers
4.4 List of Vendors in the Value Chain
5. Nutraceuticals Market – Key Market Dynamics
5.1 Nutraceuticals Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Consumer Focus on Preventive Health
5.2.2 Innovations and Strategic Developments by Market Players
5.3 Market Restraints
5.3.1 Complexity of Regulations
5.4 Market Opportunities
5.4.1 Rising Penetration of E-Commerce
5.5 Future Trends
5.5.1 Plant-Based and Organic Nutraceuticals
5.6 Impact of Drivers and Restraints:
6. Nutraceuticals Market – Global Market Analysis
6.1 Nutraceuticals Market Revenue (US$ Billion), 2021–2031
6.2 Nutraceuticals Market Forecast Analysis
7. Nutraceuticals Market Analysis – by Type
7.1 Functional Foods
7.1.1 Overview
7.1.2 Functional Foods: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
7.2 Functional Beverages
7.2.1 Overview
7.2.2 Functional Beverages: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
7.3 Dietary Supplements
7.3.1 Overview
7.3.2 Dietary Supplements: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
7.3.3 General Wellness
7.3.3.1 Overview
7.3.3.2 General Wellness: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
7.3.4 Sports Nutrition
7.3.4.1 Overview
7.3.4.2 Sports Nutrition: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
7.3.5 Weight Management
7.3.5.1 Overview
7.3.5.2 Weight Management: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
7.3.6 Immune Health
7.3.6.1 Overview
7.3.6.2 Immune Health: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
7.3.7 Others
7.3.7.1 Overview
7.3.7.2 Others: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
8. Nutraceuticals Market Analysis – by Distribution Channel
8.1 Supermarkets and Hypermarkets
8.1.1 Overview
8.1.2 Supermarkets and Hypermarkets: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
8.2 Specialty Stores
8.2.1 Overview
8.2.2 Specialty Stores: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
8.3 Online Retail
8.3.1 Overview
8.3.2 Online Retail: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
8.4 Convenience Stores
8.4.1 Overview
8.4.2 Convenience Stores: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
8.5 Others
8.5.1 Overview
8.5.2 Others: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9. Nutraceuticals Market – Geographical Analysis
9.1 Overview
9.2 North America
9.2.1 North America Nutraceuticals Market Overview
9.2.2 North America: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.2.3 North America: Nutraceuticals Market Breakdown, by Type
9.2.3.1 North America: Nutraceuticals Market – Revenue and Forecast Analysis – by Type
9.2.4 North America: Nutraceuticals Market Breakdown, by Distribution Channel
9.2.4.1 North America: Nutraceuticals Market – Revenue and Forecast Analysis – by Distribution Channel
9.2.5 North America: Nutraceuticals Market – Revenue and Forecast Analysis – by Country
9.2.5.1 North America: Nutraceuticals Market – Revenue and Forecast Analysis – by Country
9.2.5.2 United States: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.2.5.2.1 United States: Nutraceuticals Market Breakdown, by Type
9.2.5.2.2 United States: Nutraceuticals Market Breakdown, by Distribution Channel
9.2.5.3 Canada: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.2.5.3.1 Canada: Nutraceuticals Market Breakdown, by Type
9.2.5.3.2 Canada: Nutraceuticals Market Breakdown, by Distribution Channel
9.2.5.4 Mexico: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.2.5.4.1 Mexico: Nutraceuticals Market Breakdown, by Type
9.2.5.4.2 Mexico: Nutraceuticals Market Breakdown, by Distribution Channel
9.3 Europe
9.3.1 Europe Nutraceuticals Market Overview
9.3.2 Europe: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.3.3 Europe: Nutraceuticals Market Breakdown, by Type
9.3.3.1 Europe: Nutraceuticals Market – Revenue and Forecast Analysis – by Type
9.3.4 Europe: Nutraceuticals Market Breakdown, by Distribution Channel
9.3.4.1 Europe: Nutraceuticals Market – Revenue and Forecast Analysis – by Distribution Channel
9.3.5 Europe: Nutraceuticals Market – Revenue and Forecast Analysis – by Country
9.3.5.1 Europe: Nutraceuticals Market – Revenue and Forecast Analysis – by Country
9.3.5.2 Germany: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.3.5.2.1 Germany: Nutraceuticals Market Breakdown, by Type
9.3.5.2.2 Germany: Nutraceuticals Market Breakdown, by Distribution Channel
9.3.5.3 France: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.3.5.3.1 France: Nutraceuticals Market Breakdown, by Type
9.3.5.3.2 France: Nutraceuticals Market Breakdown, by Distribution Channel
9.3.5.4 Italy: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.3.5.4.1 Italy: Nutraceuticals Market Breakdown, by Type
9.3.5.4.2 Italy: Nutraceuticals Market Breakdown, by Distribution Channel
9.3.5.5 Spain: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.3.5.5.1 Spain: Nutraceuticals Market Breakdown, by Type
9.3.5.5.2 Spain: Nutraceuticals Market Breakdown, by Distribution Channel
9.3.5.6 United Kingdom: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.3.5.6.1 United Kingdom: Nutraceuticals Market Breakdown, by Type
9.3.5.6.2 United Kingdom: Nutraceuticals Market Breakdown, by Distribution Channel
9.3.5.7 Rest of Europe: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.3.5.7.1 Rest of Europe: Nutraceuticals Market Breakdown, by Type
9.3.5.7.2 Rest of Europe: Nutraceuticals Market Breakdown, by Distribution Channel
9.4 Asia Pacific
9.4.1 Asia Pacific Nutraceuticals Market Overview
9.4.2 Asia Pacific: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.4.3 Asia Pacific: Nutraceuticals Market Breakdown, by Type
9.4.3.1 Asia Pacific: Nutraceuticals Market – Revenue and Forecast Analysis – by Type
9.4.4 Asia Pacific: Nutraceuticals Market Breakdown, by Distribution Channel
9.4.4.1 Asia Pacific: Nutraceuticals Market – Revenue and Forecast Analysis – by Distribution Channel
9.4.5 Asia Pacific: Nutraceuticals Market – Revenue and Forecast Analysis – by Country
9.4.5.1 Asia Pacific: Nutraceuticals Market – Revenue and Forecast Analysis – by Country
9.4.5.2 China: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.4.5.2.1 China: Nutraceuticals Market Breakdown, by Type
9.4.5.2.2 China: Nutraceuticals Market Breakdown, by Distribution Channel
9.4.5.3 Japan: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.4.5.3.1 Japan: Nutraceuticals Market Breakdown, by Type
9.4.5.3.2 Japan: Nutraceuticals Market Breakdown, by Distribution Channel
9.4.5.4 India: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.4.5.4.1 India: Nutraceuticals Market Breakdown, by Type
9.4.5.4.2 India: Nutraceuticals Market Breakdown, by Distribution Channel
9.4.5.5 Australia: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.4.5.5.1 Australia: Nutraceuticals Market Breakdown, by Type
9.4.5.5.2 Australia: Nutraceuticals Market Breakdown, by Distribution Channel
9.4.5.6 South Korea: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.4.5.6.1 South Korea: Nutraceuticals Market Breakdown, by Type
9.4.5.6.2 South Korea: Nutraceuticals Market Breakdown, by Distribution Channel
9.4.5.7 Rest of Asia Pacific: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.4.5.7.1 Rest of Asia Pacific: Nutraceuticals Market Breakdown, by Type
9.4.5.7.2 Rest of Asia Pacific: Nutraceuticals Market Breakdown, by Distribution Channel
9.5 Middle East and Africa
9.5.1 Middle East and Africa Nutraceuticals Market Overview
9.5.2 Middle East and Africa: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.5.3 Middle East and Africa: Nutraceuticals Market Breakdown, by Type
9.5.3.1 Middle East and Africa: Nutraceuticals Market – Revenue and Forecast Analysis – by Type
9.5.4 Middle East and Africa: Nutraceuticals Market Breakdown, by Distribution Channel
9.5.4.1 Middle East and Africa: Nutraceuticals Market – Revenue and Forecast Analysis – by Distribution Channel
9.5.5 Middle East and Africa: Nutraceuticals Market – Revenue and Forecast Analysis – by Country
9.5.5.1 Middle East and Africa: Nutraceuticals Market – Revenue and Forecast Analysis – by Country
9.5.5.2 South Africa: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.5.5.2.1 South Africa: Nutraceuticals Market Breakdown, by Type
9.5.5.2.2 South Africa: Nutraceuticals Market Breakdown, by Distribution Channel
9.5.5.3 Saudi Arabia: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.5.5.3.1 Saudi Arabia: Nutraceuticals Market Breakdown, by Type
9.5.5.3.2 Saudi Arabia: Nutraceuticals Market Breakdown, by Distribution Channel
9.5.5.4 United Arab Emirates: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.5.5.4.1 United Arab Emirates: Nutraceuticals Market Breakdown, by Type
9.5.5.4.2 United Arab Emirates: Nutraceuticals Market Breakdown, by Distribution Channel
9.5.5.5 Rest of Middle East and Africa: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.5.5.5.1 Rest of Middle East and Africa: Nutraceuticals Market Breakdown, by Type
9.5.5.5.2 Rest of Middle East and Africa: Nutraceuticals Market Breakdown, by Distribution Channel
9.6 South and Central America
9.6.1 South and Central America Nutraceuticals Market Overview
9.6.2 South and Central America: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.6.3 South and Central America: Nutraceuticals Market Breakdown, by Type
9.6.3.1 South and Central America: Nutraceuticals Market – Revenue and Forecast Analysis – by Type
9.6.4 South and Central America: Nutraceuticals Market Breakdown, by Distribution Channel
9.6.4.1 South and Central America: Nutraceuticals Market – Revenue and Forecast Analysis – by Distribution Channel
9.6.5 South and Central America: Nutraceuticals Market – Revenue and Forecast Analysis – by Country
9.6.5.1 South and Central America: Nutraceuticals Market – Revenue and Forecast Analysis – by Country
9.6.5.2 Brazil: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.6.5.2.1 Brazil: Nutraceuticals Market Breakdown, by Type
9.6.5.2.2 Brazil: Nutraceuticals Market Breakdown, by Distribution Channel
9.6.5.3 Argentina: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.6.5.3.1 Argentina: Nutraceuticals Market Breakdown, by Type
9.6.5.3.2 Argentina: Nutraceuticals Market Breakdown, by Distribution Channel
9.6.5.4 Rest of South and Central America: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
9.6.5.4.1 Rest of South and Central America: Nutraceuticals Market Breakdown, by Type
9.6.5.4.2 Rest of South and Central America: Nutraceuticals Market Breakdown, by Distribution Channel
10. Competitive Landscape
10.1 Heat Map Analysis by Key Players
10.2 Company Positioning & Concentration
11. Industry Landscape
11.1 Overview
11.2 Agreements, Collaborations, And Joint Ventures
11.3 Product Launch
11.4 Expansions And Other Strategic Developments
12. Company Profiles
12.1 Glanbia Plc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 NOW Health Group Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Amway Corp
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Nature's Bounty
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Garden of Life LLC
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Danone SA
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 GNC Holdings LLC
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Quest Nutrition LLC
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Kellanova
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Chobani LLC
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
List of Tables
Table 1. Nutraceuticals Market Segmentation
Table 2. List of Vendors
Table 3. Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
Table 4. Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion) – by Type
Table 5. Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion) – by Distribution Channel
Table 6. North America: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Type
Table 7. North America: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Distribution Channel
Table 8. North America: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Country
Table 9. United States: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Type
Table 10. United States: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Distribution Channel
Table 11. Canada: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Type
Table 12. Canada: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Distribution Channel
Table 13. Mexico: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Type
Table 14. Mexico: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Distribution Channel
Table 15. Europe: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Type
Table 16. Europe: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Distribution Channel
Table 17. Europe: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Country
Table 18. Germany: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Type
Table 19. Germany: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Distribution Channel
Table 20. France: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Type
Table 21. France: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Distribution Channel
Table 22. Italy: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Type
Table 23. Italy: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Distribution Channel
Table 24. Spain: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Type
Table 25. Spain: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Distribution Channel
Table 26. United Kingdom: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Type
Table 27. United Kingdom: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Distribution Channel
Table 28. Rest of Europe: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Type
Table 29. Rest of Europe: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Distribution Channel
Table 30. Asia Pacific: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Type
Table 31. Asia Pacific: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Distribution Channel
Table 32. Asia Pacific: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Country
Table 33. China: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Type
Table 34. China: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Distribution Channel
Table 35. Japan: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Type
Table 36. Japan: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Distribution Channel
Table 37. India: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Type
Table 38. India: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Distribution Channel
Table 39. Australia: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Type
Table 40. Australia: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Distribution Channel
Table 41. South Korea: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Type
Table 42. South Korea: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Distribution Channel
Table 43. Rest of Asia Pacific: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Type
Table 44. Rest of Asia Pacific: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Distribution Channel
Table 45. Middle East and Africa: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Type
Table 46. Middle East and Africa: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Distribution Channel
Table 47. Middle East and Africa: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Country
Table 48. South Africa: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Type
Table 49. South Africa: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Distribution Channel
Table 50. Saudi Arabia: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Type
Table 51. Saudi Arabia: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Distribution Channel
Table 52. United Arab Emirates: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Type
Table 53. United Arab Emirates: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Distribution Channel
Table 54. Rest of Middle East and Africa: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Type
Table 55. Rest of Middle East and Africa: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Distribution Channel
Table 56. South and Central America: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Type
Table 57. South and Central America: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Distribution Channel
Table 58. South and Central America: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Country
Table 59. Brazil: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Type
Table 60. Brazil: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Distribution Channel
Table 61. Argentina: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Type
Table 62. Argentina: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Distribution Channel
Table 63. Rest of South and Central America: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Type
Table 64. Rest of South and Central America: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion) – by Distribution Channel
List of Figures
Figure 1. Nutraceuticals Market Segmentation, by Geography
Figure 2. Ecosystem: Nutraceuticals Market
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Nutraceuticals Market Revenue (US$ Billion), 2021–2031
Figure 5. Nutraceuticals Market Share (%) – by Type (2023 and 2031)
Figure 6. Functional Foods: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
Figure 7. Functional Beverages: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
Figure 8. Dietary Supplements: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
Figure 9. General Wellness: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
Figure 10. Sports Nutrition: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
Figure 11. Weight Management: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
Figure 12. Immune Health: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
Figure 13. Others: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
Figure 14. Nutraceuticals Market Share (%) – by Distribution Channel (2023 and 2031)
Figure 15. Supermarkets and Hypermarkets: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
Figure 16. Specialty Stores: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
Figure 17. Online Retail: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
Figure 18. Convenience Stores: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
Figure 19. Others: Nutraceuticals Market – Revenue and Forecast to 2031 (US$ Billion)
Figure 20. Nutraceuticals Market Breakdown by Region, 2023 and 2031 (%)
Figure 21. North America: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion)
Figure 22. North America: Nutraceuticals Market Breakdown, by Type (2023 and 2031)
Figure 23. North America: Nutraceuticals Market Breakdown, by Distribution Channel (2023 and 2031)
Figure 24. North America: Nutraceuticals Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 25. United States: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion)
Figure 26. Canada: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion)
Figure 27. Mexico: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion)
Figure 28. Europe: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion)
Figure 29. Europe: Nutraceuticals Market Breakdown, by Type (2023 and 2031)
Figure 30. Europe: Nutraceuticals Market Breakdown, by Distribution Channel (2023 and 2031)
Figure 31. Europe: Nutraceuticals Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 32. Germany: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion)
Figure 33. France: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion)
Figure 34. Italy: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion)
Figure 35. Spain: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion)
Figure 36. United Kingdom: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion)
Figure 37. Rest of Europe: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion)
Figure 38. Asia Pacific: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion)
Figure 39. Asia Pacific: Nutraceuticals Market Breakdown, by Type (2023 and 2031)
Figure 40. Asia Pacific: Nutraceuticals Market Breakdown, by Distribution Channel (2023 and 2031)
Figure 41. Asia Pacific: Nutraceuticals Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 42. China: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion)
Figure 43. Japan: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion)
Figure 44. India: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion)
Figure 45. Australia: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion)
Figure 46. South Korea: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion)
Figure 47. Rest of Asia Pacific: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion)
Figure 48. Middle East and Africa: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion)
Figure 49. Middle East and Africa: Nutraceuticals Market Breakdown, by Type (2023 and 2031)
Figure 50. Middle East and Africa: Nutraceuticals Market Breakdown, by Distribution Channel (2023 and 2031)
Figure 51. Middle East and Africa: Nutraceuticals Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 52. South Africa: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion)
Figure 53. Saudi Arabia: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion)
Figure 54. United Arab Emirates: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion)
Figure 55. Rest of Middle East and Africa: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion)
Figure 56. South and Central America: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion)
Figure 57. South and Central America: Nutraceuticals Market Breakdown, by Type (2023 and 2031)
Figure 58. South and Central America: Nutraceuticals Market Breakdown, by Distribution Channel (2023 and 2031)
Figure 59. South and Central America: Nutraceuticals Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 60. Brazil: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion)
Figure 61. Argentina: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion)
Figure 62. Rest of South and Central America: Nutraceuticals Market – Revenue and Forecast to 2031(US$ Billion)
Figure 63. Heat Map Analysis by Key Players
Figure 64. Company Positioning & Concentration
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Get Free Sample For